Color gradient background for Challenges in CLL

Challenges in CLL

Challenges in CLL: how could the data from ASH 2022 impact your clinical practice?

30 November 2022 - 59 Minutes

Faculty

John Gribben

Paolo Ghia

Othman Al-Sawaf

EM-92737

Challenges in CLL: Continuous, time-limited, or MRD-guided therapy

8 November 2022 - 46 Minutes

Faculty

Paolo Ghia

Talha Munir

José Carda

EM-92734

Challenges in CLL: How risk stratification can guide the choice of first-line treatment in patients with CLL

13 September 2022 - 47 Minutes

Faculty

John Gribben

Carol Moreno

Ruth Clifford

Paolo Sportoletti

EM-93552

Challenges in CLL: how does the data from EHA 2022 inform key management questions?

21 June 2022 - 63 Minutes

Faculty

John Gribben

Paolo Ghia

EM-78442

Challenges in CLL: What does the future hold - are we approaching cure in CLL?

17 May 2022 - 46 Minutes

Faculty

John Gribben

Stephan Stilgenbauer

EM-78439

Challenges in CLL: Where are we with MRD assessment?

5 May 2022 - 46 Minutes

Faculty

Paolo Ghia

EM-78437

Challenges in CLL: Standards of care or precision medicine: what applies in CLL?

29 March 2022 - 46 Minutes

Faculty

John Gribben

Carol Moreno

Paolo Ghia

EM-78435